phase readout

NCT06118086: Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

RECRUITINGupdated 17m ago

community read0 votes

Sponsor: Remix Therapeutics. Phase: PHASE1. Conditions: Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma

view source ↗

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ctgov

last refreshed 17m ago

Found something off?